Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design

Cephalalgia

Volumn 32, Issue 11, 2012, Pages 834-844

  Munksgaard, Signe B ^a   Bendtsen, Lars ^a   Jensen, Rigmor H ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

cost efficiency; educational programme; Medication overuse headache; multidisciplinary treatment; outpatient treatment; prophylactic treatment

Indexed keywords

ANALGESIC AGENT; LEVOMEPROMAZINE; METOCLOPRAMIDE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PROMETHAZINE; TRIPTAN DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DETOXIFICATION; DRUG INDUCED HEADACHE; FEASIBILITY STUDY; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; HUMAN; INTERDISCIPLINARY EDUCATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; OUTCOME ASSESSMENT; OUTPATIENT CARE; PHYSIOTHERAPY; PROPHYLAXIS; QUESTIONNAIRE; TREATMENT PLANNING; TREATMENT WITHDRAWAL;

ADULT; AGED; ANALGESICS; DENMARK; FEMALE; HEADACHE DISORDERS, SECONDARY; HUMANS; MALE; MIDDLE AGED; PAIN CLINICS; PAIN MANAGEMENT; PATIENT CARE TEAM; PREVALENCE; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864642676     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102412451363     Document Type: Article

References (38)

1. Haag G, Baar H, Grotemeyer KH, et al. Prophylaxe und Therapie des medikamenteninduzierten Dauerkopfschmerzes. Schmerz. 1999 ; 13: 52-57
2. Zeeberg P, Olesen J, Jensen R. Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology. 2006 ; 66: 1894-1898
3. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
4. Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medication-overuse headache. Lancet Neurol. 2010 ; 9: 391-401
5. Diener HC, Silberstein SD The headaches. Olesen J Goadsby PJ Ramadan N, ed. Philadelphia: Lippincott Williams & Wilkins ; 2006: 971-979.
6. The international classification of headache disorders, 2nd edn. Cephalalgia. 2004 ; 24 (Suppl 1). 9-160
7. Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006 ; 26: 1192-1198
8. Hagen K, Albretsen C, Vilming S, et al. Management of medication overuse headache: 1-year randomized multicentre open-label trial. Cephalalgia. 2009 ; 29: 221-232
9. Diener HC, Dodick DW, Goadsby PJ, et al. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 ; 29: 1021-1027
10. Mei D, Ferraro D, Zelano G, et al. Topiramate and triptans revert chronic migraine with medication overuse to episodic migraine. Clin Neuropharmacol. 2006 ; 29: 269-275
11. Diener HC, Dodick DW, Aurora SK, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010 ; 30: 804-814
12. Aurora SK, Dodick DW, Turkel CC, et al. OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia. 2010 ; 30: 793-803
13. Munksgaard SB, Bendtsen L, Jensen RH. Treatment-resistant medication overuse headache can be cured. Headache. :
14. Jensen R, Zeeberg P, Dehlendorff C, Olesen J. Predictors of outcome of the treatment programme in a multidisciplinary headache centre. Cephalalgia. 2010 ; 30: 1214-1224
15. Russell MB, Rasmussen BK, Brennum J, et al. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992 ; 12: 369-374
16. Stewart WF, Lipton RB, Dowson AJ, Sawyer J. Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability. Neurology. 2001 ; 56 (Suppl). 20-28
17. Saxena S, Orley J. Quality of life assessment: the world health organization perspective. Eur Psychiatry. 1997 ; 12 (Suppl 3). 263-266
18. Crawford JR, Henry JD, Crombie C, Taylor EP. Normative data for the HADS from a large non-clinical sample. Br J Clin Psychol. 2001 ; 40: 429-434
19. Hagen K, Jensen R, Boe MG, Stovner LJ. Medication overuse headache: a critical review of end points in recent follow-up studies. J Headache Pain. 2010 ; 11: 373-377
20. Diener HC. Detoxification for medication overuse headache is not necessary. Cephalalgia. 2012 ; 32: 423-427
21. Olesen J. Detoxification is the primary task in overusing patients. Cephalalgia. 2012 ; 32: 420-422
22. Diener HC, Bussone G, van Oene JC, et al. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 ; 27: 814-823
23. Sandrini G, Perrotta A, Tassorelli C, et al. Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study. J Headache Pain. 2011 ; 12: 427-433
24. Bøe MG, Salvesen R, Mygland A. Chronic daily headache with medication overuse: a randomized follow-up by neurologist or PCP. Cephalalgia. 2009 ; 29: 855-863
25. Katsarava Z, Limmroth V, Finke M, et al. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology. 2003 ; 60: 1682-1683
26. Sances G, Ghiotto N, Galli F, et al. Risk factors in medication-overuse headache: a 1-year follow-up study (care II protocol). Cephalalgia. 2010 ; 30: 329-336
27. Munksgaard SB, Allena M, Tassorelli C, et al. What do the patients with medication overuse headache expect from treatment and what are the preferred sources of information?. J Headache Pain. 2011 ; 12: 91-96
28. Gaul C, Visscher CM, Bhola R, et al. Team players against headache: multidisciplinary treatment of primary headaches and medication overuse headache. J Headache Pain. 2011 ; 12: 511-519
29. Holroyd HA, Cottrell CK, O'Donnell FJ, et al. Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial. BMJ. 2010 ; 341: c4871 - c4871
30. Rossi P, Faroni JV, Nappi G. Short-term effectiveness of simple advice as a withdrawal strategy in simple and complicated medication overuse headache. Eur J Neurol. 2010 ; 18: 396-401
31. Gaul C, van Doorn C, Webering N, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J. Headache Pain. 2011 ; 12: 475-483
32. Tassorelli C, Sances G, Allena M, et al. The usefulness and applicability of a basic headache diary before first consultation: results of a pilot study conducted in two centres. Cephalalgia. 2008 ; 28: 1023-1030
33. Grande RB, Aaseth K, Benth JS, et al. Reduction in medication-overuse headache after short information. The Akershus study of chronic headache. Eur J Neurol. 2011 ; 18: 129-137
34. Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, et al. Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up. Cephalalgia. 2007 ; 27: 1219-1225
35. Andrasik F Grazzi L, Usai S, et al. Disability in chronic migraine with medication overuse: treatment effects at 3 years. Headache. 2007 ; 47: 1277-1281
36. Rossi P, Faroni JV, Nappi G. Medication overuse headache: predictors and rates of relapse in migraine patients with low medical needs. A 1-year prospective study. Cephalalgia. 2008 ; 28: 1196-1200
37. Usai S, Grazzi L, D'Amico D, et al. Psychological variables in chronic migraine with medication overuse before and after inpatient withdrawal: results at 1-year follow-up. Neurol Sci. 2009 ; 30 (Suppl 1). 125-127
38. Grazzi L, Andrasik F, Usai S, Bussone G. In-patient vs. day-hospital withdrawal treatment for chronic migraine with medication overuse and disability assessment: results at one-year follow-up. Neurol Sci. 2008 ; 29 (Suppl 1). 161-163